Header Logo

Connection

Stanley Hsia to Anti-Obesity Agents

Back to Details
This is a "connection" page, showing publications Stanley Hsia has written about Anti-Obesity Agents.
Stanley Hsia
Connection Strength
0.237
Anti-Obesity Agents
  1. Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2025 Dec 06; 406(10520):2631-2643.
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.